K410-0835 Screening compound: N~1~-[2-(2,4-dimethylphenyl)-5,5-dioxo-2,4,5,6-tetrahydro-5lambda~6~-thieno[3,4-c]pyrazol-3-yl]-3-methylbenzamide

K410-0835 Screening compound: N~1~-[2-(2,4-dimethylphenyl)-5,5-dioxo-2,4,5,6-tetrahydro-5lambda~6~-thieno[3,4-c]pyrazol-3-yl]-3-methylbenzamide
K410-0835 Screening compound: N~1~-[2-(2,4-dimethylphenyl)-5,5-dioxo-2,4,5,6-tetrahydro-5lambda~6~-thieno[3,4-c]pyrazol-3-yl]-3-methylbenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K410-0835
N~1~-[2-(2,4-dimethylphenyl)-5,5-dioxo-2,4,5,6-tetrahydro-5lambda~6~-thieno[3,4-c]pyrazol-3-yl]-3-methylbenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K410-0835

Molecular Formula

C21H21N3O3S (C21 H21 N3 O3 S)

Compound Name

N~1~-[2-(2,4-dimethylphenyl)-5,5-dioxo-2,4,5,6-tetrahydro-5lambda~6~-thieno[3,4-c]pyrazol-3-yl]-3-methylbenzamide

IUPAC name

N-[2-(24-dimethylphenyl)-55-dioxo-2H4H6H-5lambda6-thieno[34-c]pyrazol-3-yl]-3-methylbenzamide

SMILES

Cc1cccc(C(Nc2c(CS(C3)(=O)=O)c3nn2-c2c(C)cc(C)cc2)=O)c1

InChI

InChI=1S/C21H21N3O3S/c1-13-5-4-6-16(10-13)21(25)22-20-17-11-28(26,27)12-18(17)23-24(20)19-8-7-14(2)9-15(19)3/h4-10H,11-12H2,1-3H3,(H,22,25)

InChI Key

BXJPAEZKMWDMKZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD04452609

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

395.48

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.613

Distribution Coefficient, logD

3.583

Water Solubility, LogSw

-3.95

Polar Surface Area

66.400

Acid Dissociation Constant (pKa)

8.53

Base Dissociation Constant (pKb)

-2.64

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.80

K410-0835 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Mechanism of action:
  • Epigenetic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with K410-0835 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K410-0835?
Check Price and Availability of K410-0835, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K410-0835 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K410-0835
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K410-0835
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K410-0835 available by request